Cathie Wood’s ARK ETFs have made some notable moves in their portfolio recently. They have bought shares of CRISPR Therapeutics (CRSP) and BWX Technologies (BWXT), while selling off positions in Roblox (RBLX) and Rocket Lab (RKLB) stocks.
CRISPR Therapeutics is a leading player in the field of gene editing technology, which has immense potential for revolutionizing healthcare. BWX Technologies, on the other hand, is a prominent supplier of nuclear components and fuel for the U.S. government.
On the selling side, Roblox is a popular gaming platform that has seen a surge in users during the pandemic, but ARK ETFs have decided to part ways with the stock. Rocket Lab, a space technology company, has also been sold off by the ETFs.
These moves by ARK ETFs indicate their confidence in the growth prospects of CRISPR Therapeutics and BWX Technologies, while also showing their decision to reduce exposure to Roblox and Rocket Lab. It will be interesting to see how these changes play out in the future performance of the ETFs.